vortioxetine hydrobromide
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
12 FDA-registered drug labelers
APICORE PHARMACEUTICALS PRIVATE LIMITED
Cardinal Health 107, LLC
HETERO LABS LIMITED
Lundbeck Pharmaceuticals Italy S.p.A.
Metrochem API Private Limited
MSN Pharmachem Private Limited
REMEDYREPACK INC.
Takeda GmbH
Takeda Pharmaceuticals America, Inc.
Unichem Laboratories Limited, India
Zhejiang Lepu Pharmaceutical Co., Ltd.
Zhejianghuahai Pharmaceutical.co.,ltd.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Trintellix
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS960203-27-4
PubChem CID56843850
DTXSIDDTXSID501027850
FormulaC18H23BrN2S
Mol. Weight379.4 g/mol
SMILESCC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C.Br
Data Sources
568438502026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/vortioxetine hydrobromide/cids/JSON
Archive: data/sources/pubchem_name/vortioxetine hydrobromide.json
CAS 960203-27-42026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json